Thromboxane A2Antagonistic Action of a New Anti-Ulcer Agent, Azuletil Sodium (KT1-32)
- 1 January 1989
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 24 (sup162) , 194-197
- https://doi.org/10.3109/00365528909091159
Abstract
The TXA2/PGH2 receptor antagonistic activity of azuletil sodium (KT1-32), a new anti-ulcer agent, was examined. KT1-32 competitively antagonized the contraction of canine gastric arteries induced by U-46619, PGF2 alpha, and PGE2, whereas it had no effect on the PGF2 alpha-, PGE2- and LTD4-induced contraction of guinea-pig ileum, which was not affected by U-46619. In anesthetized dogs, KT1-32 significantly reduced the U-46619-induced decrease in gastric arterial blood flow. Gastric contraction induced by U-46619 in anesthetized rats was markedly inhibited by KT1-32. KT1-32 showed no influence on TXA2 synthetase and cyclooxygenase activities. These results indicate that KT1-32 is a competitive TXA2/PGH2 receptor antagonist, which may be important as to the effectiveness of KT1-32 against gastric ulcer.Keywords
This publication has 5 references indexed in Scilit:
- Gastric mucosal protection by new aryl sulfhydryl drugsDigestive Diseases and Sciences, 1988
- Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosaProstaglandins, 1988
- Studies on the mechanism of ethanol-induced gastric damage in ratsPublished by Elsevier ,1988
- Effects of KT1-32 on acute gastric lesions and duodenal ulcers induced in rats.Folia Pharmacologica Japonica, 1986
- Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy.Gut, 1985